The analysis of RNA-seq or scRNA-seq datasets from studies comparing T-cell-infiltrating tumor tissue with those from NAT and blood in breast carcinoma, CRC and NSCLC [43,44,46,79] highlighted an increased IL1R2 gene expression on TA-Tregs. This evidence concerns the gene IL1R2 and breast carcinoma.